DOI QR코드

DOI QR Code

Anti-melanogenic property of ginsenoside Rf from Panax ginseng via inhibition of CREB/MITF pathway in melanocytes and ex vivo human skin

  • Lee, Ha-Ri (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Joon Min (Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seo, Ji-Yeon (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chang, Sung Eun (Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Youngsup (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2020.06.26
  • Accepted : 2020.11.16
  • Published : 2021.09.30

Abstract

Background: Ginsenosides of Panax ginseng are used to enhance skin health and beauty. The present study aimed to investigate the potential use of ginsenoside Rf (Rf) from Panax ginseng as a new anti-pigmentation agent. Methods: The anti-melanogenic effects of Rf were explored. The transcriptional activity of the cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) and the expression levels of tyrosinase, microphthalmia-associated transcription factor (MITF), and tyrosinase-related proteins (Tyrps) were evaluated in melanocytes and UV-irradiated ex vivo human skin. Results: Rf significantly inhibited Forskolin (FSK) or UV-stimulated melanogenesis. Consistently, cellular tyrosinase activity and levels of MITF, tyrosinase, and Tyrps were downregulated. Furthermore, Rf suppressed MITF promoter activity, which was stimulated by FSK or CREB-regulated transcription coactivator 3 (CRTC3) overexpression. Increased CREB phosphorylation and protein kinase A (PKA) activity induced by FSK were also mitigated in the presence of Rf. Conclusion: Rf can be used as a reliable anti-pigmentation agent, which has a scientifically confirmed and reproducible action mechanism, via inhibition of CREB/MITF pathway.

Keywords

Acknowledgement

We thank Dr. Jin-Hwan Oh and Yul Hur for providing ginsenoside Rf, Dr. Montminy at the Salk Institute for Biological Studies for providing sera antibodies to CREB and phospho-CREB, and Professor Park at Department of Dermatology, Seoul National University, Bundang Hospital, Seongnam, Korea for providing Mel-Ab cells.

References

  1. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Research 2003;16:101-10. https://doi.org/10.1034/j.1600-0749.2003.00029.x
  2. Engasser PG, Maibach HI. Cosmetics and dermatology: bleaching creams. Journal of the American Academy of Dermatology 1981;5:143-7. https://doi.org/10.1016/S0190-9622(81)70082-3
  3. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. Biofactors 2009;35:193-9. https://doi.org/10.1002/biof.29
  4. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews 2004;84:1155-228. https://doi.org/10.1152/physrev.00044.2003
  5. Bang S, Won KH, Moon HR, Yoo H, Hong A, Song Y, Chang SE. Novel regulation of melanogenesis by adiponectin via the AMPK/CRTC pathway. Pigment Cell Melanoma Res 2017;30:553-7. https://doi.org/10.1111/pcmr.12596
  6. Kim J-H, Hong A-r, Kim Y-H, Yoo H, Kang S-W, Chang SE, Song Y. JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression. Theranostics 2020;10:4017. https://doi.org/10.7150/thno.41502
  7. Kwak Y-S. Bibliographic consideration on the efficacy and the origin of Korean ginseng. Journal of Ginseng Culture 2019;1:43-56. https://doi.org/10.23076/JGC.2019.1.043
  8. Wei X, Chen J, Su F, Su X, Hu T, Hu S. Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. International Immunology 2012;24:465-71. https://doi.org/10.1093/intimm/dxs043
  9. Joo SS, Yoo YM, Ahn BW, Nam SY, Kim Y-B, Hwang KW, Lee DI. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biological and Pharmaceutical Bulletin 2008;31:1392-6. https://doi.org/10.1248/bpb.31.1392
  10. Rivera E, Hu S, Concha C. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 2003;21:1149-57. https://doi.org/10.1016/S0264-410X(02)00518-2
  11. Rivera E, Pettersson FE, Inganas M, Paulie S, Gronvik K-O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005;23:5411-9. https://doi.org/10.1016/j.vaccine.2005.04.007
  12. So MW, Lee E-J, Lee HS, San Koo B, Kim Y-G, Lee C-K, Yoo B. Protective effects of ginsenoside Rg3 on human osteoarthritic chondrocytes. Modern Rheumatology 2013;23:104-11. https://doi.org/10.3109/s10165-012-0635-8
  13. Wei X, Su F, Su X, Hu T, Hu S. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia 2012;83:636-42. https://doi.org/10.1016/j.fitote.2012.01.006
  14. Jimenez-P erez ZE, Kim Y-J, Castro-Aceituno V, Mathiyalagan R, Markus J, Ahn S, Simu SY, Yang D-C. Novel application of cultured roots of mountain ginseng (Panax ginseng meyer) and ginsenoside re as safe antimelanogenic cosmeceutical components. African Journal of Traditional, Complementary and Alternative Medicines 2017;14:209-18.
  15. Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H, Arichi S. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Research 1985;45:2781-4.
  16. Lee DY, Lee J, Jeong YT, Byun GH, Kim JH. Melanogenesis inhibition activity of floralginsenoside A from Panax ginseng berry. Journal of Ginseng Research 2017;41:602-7. https://doi.org/10.1016/j.jgr.2017.03.005
  17. Lee SJ, Lee WJ, Chang SE, Lee G-Y. Antimelanogenic effect of ginsenoside Rg3 through extracellular signal-regulated kinase-mediated inhibition of microphthalmia-associated transcription factor 2015;39:238-42. https://doi.org/10.1016/j.jgr.2015.01.001
  18. Qin X, Liu Y, Feng Y, Jiang J. Ginsenoside Rf alleviates dysmenorrhea and inflammation through the BDNF-TrkB-CREB pathway in a rat model of endometriosis. Food Funct 2019;10:244-9. https://doi.org/10.1039/C8FO01839A
  19. Lee H, Gonzalez FJ, Yoon M. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun 2006;339:196-203. https://doi.org/10.1016/j.bbrc.2005.10.197
  20. Ahn S, Siddiqi MH, Aceituno VC, Simu SY, Yang DC. Suppression of MAPKs/NF-kappaB activation induces intestinal anti-inflammatory action of ginsenoside Rf in HT-29 and RAW264.7 cells. Immunol Invest 2016;45:439-49. https://doi.org/10.3109/08820139.2016.1168830
  21. Kim MK, Kang H, Baek CW, Jung YH, Woo YC, Choi GJ, Shin HY, Kim KS. Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain. J Ginseng Res 2018;42:183-91. https://doi.org/10.1016/j.jgr.2017.02.005
  22. Li Y, Chen C, Li S, Jiang C. Ginsenoside Rf relieves mechanical hypersensitivity, depression-like behavior, and inflammatory reactions in chronic constriction injury rats. Phytother Res 2019;33:1095-103. https://doi.org/10.1002/ptr.6303
  23. Siraj FM, Natarajan S, Huq MA, Kim YJ, Yang DC. Structural investigation of ginsenoside Rf with PPARg major transcriptional factor of adipogenesis and its impact on adipocyte. Journal of Ginseng Research 2015;39:141-7. https://doi.org/10.1016/j.jgr.2014.10.002
  24. Chen W, Balan P, Popovich DG. Analysis of ginsenoside content (Panax ginseng) from different regions. Molecules 2019;24.
  25. Chan T, But P, Cheng S, Kwok I, Lau F, Xu H. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. Analytical Chemistry 2000;72:1281-7. https://doi.org/10.1021/ac990819z
  26. Minh Nguyen H, Truong Nguyen H, Win N, Piow Wong C, Vu Huynh KL, Hoang NN, Do KM, Thi Nguyen H, Viet Ho D, Duc Nguyen M, et al. Anti-melanogenic activity of ocotillol-type saponins from Panax vietnamensis. Chem Biodivers 2020;17:e2000037.
  27. Lee DY, Kim H-G, Lee Y-G, Kim JH, Lee JW, Choi B-R, Jang I-B, Kim G-S, Baek NI. Isolation and quantification of ginsenoside Rh23, a new anti-melanogenic compound from the leaves of Panax ginseng. Molecules 2018;23:267. https://doi.org/10.3390/molecules23020267
  28. Lee DY, Jeong YT, Jeong SC, Lee MK, Min JW, Lee JW, Kim GS, Lee SE, Ahn YS, Kang HC. Melanin biosynthesis inhibition effects of Ginsenoside Rb2 isolated from Panax ginseng Berry. J Microbiol Biotechnol 2015;25:2011-5. https://doi.org/10.4014/jmb.1505.05069
  29. Liu Xy, Xiao YK, Hwang E, Haeng JJ, Yi TH. Antiphotoaging and antimelanogenesis properties of ginsenoside C-Y, a ginsenoside Rb2 metabolite from American ginseng PDD-ginsenoside. Photochemistry and Photobiology 2019;95:1412-23. https://doi.org/10.1111/php.13116
  30. Lee CS, Nam G, Bae IH, Park J. Whitening efficacy of ginsenoside F1 through inhibition of melanin transfer in cocultured human melanocytes-keratinocytes and three-dimensional human skin equivalent. J Ginseng Res 2019;43:300-4. https://doi.org/10.1016/j.jgr.2017.12.005
  31. Kim JH, Baek EJ, Lee EJ, Yeom MH, Park JS, Lee KW, Kang NJ. Ginsenoside F1 attenuates hyperpigmentation in B16F10 melanoma cells by inducing dendrite retraction and activating Rho signalling. Exp Dermatol 2015;24:150-2. https://doi.org/10.1111/exd.12586
  32. Wang D-D, Jin Y, Wang C, Kim Y-J, Perez ZEJ, Baek NI, Mathiyalagan R, Markus J, Yang D-C. Rare ginsenoside Ia synthesized from F1 by cloning and overexpression of the UDP-glycosyltransferase gene from Bacillus subtilis: synthesis, characterization, and in vitro melanogenesis inhibition activity in BL6B16 cells. Journal of Ginseng Research 2018;42:42-9. https://doi.org/10.1016/j.jgr.2016.12.009
  33. Zhou QL, Yang XW. Four new ginsenosides from red ginseng with inhibitory activity on melanogenesis in melanoma cells. Bioorg Med Chem Lett 2015;25:3112-6. https://doi.org/10.1016/j.bmcl.2015.06.017
  34. Han JS, Sung JH, Lee SK. Antimelanogenesis activity of hydrolyzed ginseng extract (GINST) via inhibition of JNK mitogen-activated protein kinase in B16F10 cells. Journal of Food Science 2016;81:H2085-92. https://doi.org/10.1111/1750-3841.13380
  35. KimM DS, Kim SY, Moon SJ, Chung JH, Kim KH, Cho KH, Park KC. Ceramide inhibits cell proliferation through Akt/PKB inactivation and decreases melanin synthesis in Mel-Ab cells. Pigment Cell Research 2001;14:110-5. https://doi.org/10.1034/j.1600-0749.2001.140206.x
  36. Kim YH, Kim D, Hong AR, Kim JH, Yoo H, Kim J, Kim I, Kang SW, Chang SE, Song Y. Therapeutic potential of rottlerin for skin hyperpigmentary disorders by inhibiting the transcriptional activity of CREB-regulated transcription coactivators. The Journal of Investigative Dermatology 2019;139:2359-67. https://doi.org/10.1016/j.jid.2019.05.012
  37. Park PJ, Lee TR, Cho E-G. Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes. Journal of Investigative Dermatology 2015;135:551-9. https://doi.org/10.1038/jid.2014.423
  38. Park CW, Kim MA, Choi Y, Kang IC. Analysis of PKC beta-mediated tyrosinase phosphorylation using ProteoChip. Biochip Journal 2012;6:391-5. https://doi.org/10.1007/s13206-012-6411-1
  39. Kim J, Kim YH, Bang S, Yoo H, Kim I, Chang SE, Song YL. 765,314 Suppresses melanin synthesis by regulating tyrosinase activity. Molecules 2019;24.
  40. Roh E, Yun CY, Young Yun J, Park D, Doo Kim N, Yeon Hwang B, Jung SH, Park SK, Kim YB, Han SB, et al. cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder. The Journal of Investigative Dermatology 2013;133:1072-9. https://doi.org/10.1038/jid.2012.425
  41. Horike N, Sakoda H, Kushiyama A, Ono H, Fujishiro M, Kamata H, Nishiyama K, Uchijima Y, Kurihara Y, Kurihara H, et al. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver. J Biol Chem 2008;283:33902-10. https://doi.org/10.1074/jbc.M802537200
  42. Lin M, Zhang B-X, Zhang C, Shen N, Zhang Y-Y, Wang A-X, Tu C-X. Ginsenosides Rb1 and Rg1 stimulate melanogenesis in human epidermal melanocytes via PKA/CREB/MITF signaling. Evid Based Complement Alternat Med 2014;2014.
  43. Kim E, Kim D, Yoo S, Hong YH, Han SY, Jeong S, Jeong D, Kim JH, Cho JY, Park J. The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng. J Ginseng Res 2018;42:218-24. https://doi.org/10.1016/j.jgr.2017.03.007
  44. Wang L, Lu AP, Yu ZL, Wong RN, Bian ZX, Kwok HH, Yue PY, Zhou LM, Chen H, Xu M, et al. The melanogenesis-inhibitory effect and the percutaneous formulation of ginsenoside Rb1. AAPS PharmSciTech 2014;15:1252-62. https://doi.org/10.1208/s12249-014-0138-3
  45. Xu XF, Gao Y, Xu SY, Liu H, Xue X, Zhang Y, Zhang H, Liu MN, Xiong H, Lin RC, et al. Remarkable impact of steam temperature on ginsenosides transformation from fresh ginseng to red ginseng. J Ginseng Res 2018;42:277-87. https://doi.org/10.1016/j.jgr.2017.02.003
  46. Im D-S. Pro-resolving effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng. Biomolecules 2020;10:444. https://doi.org/10.3390/biom10030444
  47. Yang Y, Yang WS, Yu T, Sung GH, Park KW, Yoon K, Son YJ, Hwang H, Kwak YS, Lee CM, et al. ATF-2/CREB/IRF-3-targeted anti-inflammatory activity of Korean red ginseng water extract. J Ethnopharmacol 2014;154:218-28. https://doi.org/10.1016/j.jep.2014.04.008
  48. Markey AC, Black AK, Rycroft RJ. Confetti-like depigmentation from hydroquinone. Contact Dermatitis 1989;20:148-9. https://doi.org/10.1111/j.1600-0536.1989.tb03126.x
  49. Kersey P, Stevenson CJ. Vitiligo and occupational exposure to hydroquinone from servicing self-photographing machines. Contact Dermatitis 1981;7:285-7. https://doi.org/10.1111/j.1600-0536.1981.tb04080.x
  50. Sasaki M, Kondo M, Sato K, Umeda M, Kawabata K, Takahashi Y, Suzuki T, Matsunaga K, Inoue SJPc, research m. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinasedependent mechanism 2014;27:754-63. https://doi.org/10.1111/pcmr.12269
  51. Forster M, Bolzinger MA, Fessi H, Briancon S. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. European Journal of Dermatology : EJD 2009;19:309-23. https://doi.org/10.1684/ejd.2009.0676
  52. Jeong YM, Oh WK, Tran TL, Kim WK, Sung SH, Bae K, Lee S, Sung JH. Aglycone of Rh4 inhibits melanin synthesis in B16 melanoma cells: possible involvement of the protein kinase A pathway. Biosci Biotechnol Biochem 2013;77:119-25. https://doi.org/10.1271/bbb.120602